Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals

Molecular Biology of the Cell

Volumn 15, Issue 8, 2004, Pages 3520-3529

  Swimm, Alyson ^a   Bommarius, Bettina ^a   Li, Yue ^a   Cheng, David ^a   Reeves, Patrick ^b   Sherman, Melanie ^a   Veach, Darren ^c   Bornmann, William ^c   Kalman, Daniel ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ACTIN; PROTEIN TYROSINE KINASE; PYRIDO[2,3 D]PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CELL TYPE; DIARRHEA; ENTERITIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ESCHERICHIA COLI; HOST; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY;

ACTIN-RELATED PROTEIN 2; ACTIN-RELATED PROTEIN 3; ACTINS; ANIMALS; CELL LINE; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; MICE; MICROFILAMENTS; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS; PHOSPHORYLATION; POINT MUTATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES; RECEPTORS, CELL SURFACE; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 3343010235     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-02-0093     Document Type: Article

References (62)

1. Arnaud, L., Ballif, B.A., Foerster, E., and Cooper, J.A. (2003). Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr. Biol. 13, 9-17.
2. Burton, E.A., Plattner, R., and Pendergast, A.M. (2003). Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J. 22, 5471-5479.
3. Campellone, K.G., Rankin, S., Pawson, T., Kirschner, M.W., Tipper, J., and Leong, J.M. (2004). Clustering of Nck by a 12-residue Tir phosphopeptide is sufficient to trigger localized actin assembly. J. Cell Biol. 164, 407-416.
4. Cornelis, G.R. (2000). Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. USA 97, 8778-8783.
5. de Grado, M., Abe, A., Gauthier, A., Steele-Mortimer, O., DeVinney, R., and Finlay, B.B. (1999). Identification of the intimin-binding domain of Tir of enteropathogenic Escherichia coli. Cell Microbiol. 1, 7-17.
6. Donnenberg, M.S., Yu, J., and Kaper, J.B. (1993). A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J. Bacteriol. 175, 4670-4676.
7. Dorsey, J.F., Jove, R., Kraker, A.J., and Wu, J. (2000). The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells. Cancer Res. 60, 3127-3131.
8. Druker, B.J., Sawyers, C.L., Capdeville, R., Ford, J.M., Baccarani, M., and Goldman, J.M. (2001). Chronic myelogenous leukemia. Hematology. Am. Soc. Hematol. Educ. Program 87-112.
9. Evans, E.K., Lu, W., Strum, S.L., Mayer, B.J., and Kornbluth, S. (1997). Crk is required for apoptosis in Xenopus egg extracts. EMBO J. 16, 230-241.
10. Foubister, V., Rosenshine, I., Donnenberg, M.S., and Finlay, B.B. (1994). The eaeB gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells. Infect. Immun. 62, 3038-3040.
11. Frankel, G., Lider, O., Hershkoviz, R., Mould, A.P., Kachalsky, S.G., Candy, D.C., Cahalon, L., Humphries, M.J., and Dougan, G. (1996). The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J. Biol. Chem. 271, 20359-20364.
12. Frischknecht, F., Moreau, V., Rottger, S., Gonfloni, S., Reckmann, I., Superti-Furga, G., and Way, M. (1999). Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401, 926-929.
13. Goldman, J.M., and Druker, B.J. (2001). Chronic myeloid leukemia: current treatment options. Blood 98, 2039-2042.
14. Goosney, D.L., DeVinney, R., and Finlay, B.B. (2001). Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals. Infect. Immun. 69, 3315-3333.
15. Goosney, D.L., Gruenheid, S., and Finlay, B.B. (2000). Gut feelings: enteropathogenic E. coli (EPEC) interactions with the host. Annu. Rev. Cell Dev. Biol. 16, 173-189.
16. Gorre, M.E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P.N., and Sawyers, C.L. (2001). Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876-880.
17. Gruenheid, S., DeVinney, R., Bladt, F., Goosney, D., Gelkop, S., Gish, G.D., Pawson, T., and Finlay, B.B. (2001). Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat. Cell Biol. 3, 856-859.
18. Ichaso, N., and Dilworth, S.M. (2001). Cell transformation by the middle T-antigen of polyoma virus. Oncogene. 20, 7908-7916.
19. Imamoto, A., Soriano, P., and Stein, P.L. (1994). Genetics of signal transduction: tales from the mouse. Curr. Opin. Genet. Dev. 4, 40-46.
20. Jarvis, K.G., Giron, J.A., Jerse, A.E., McDaniel, T.K., Donnenberg, M.S., and Kaper, J.B. (1995). Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. USA 92, 7996-8000.
21. Kalman, D., Gomperts, S.N., Hardy, S., Kitamura, M., and Bishop, J.M. (1999a). Ras family GTPases control growth of astrocyte processes. Mol. Biol. Cell 20, 1665-1683.
22. Kalman, D., Weiner, O.D., Goosney, D.L., Sedat, J.W., Finlay, B.B., Abo, A., and Bishop, J.M. (1999b). Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nat. Cell Biol. 1, 389-391.
23. Kenny, B. (1999). Phosphorylation of tyrosine 474 of the enteropathogenic Escherichia coli (EPEC) Tir receptor molecule is essential for actin nucleating activity and is preceded by additional host modifications. Mol. Microbiol. 31, 1229-1241.
24. Kenny, B., DeVinney, R., Stein, M., Reinscheid, D.J., Frey, E.A., and Finlay, B.B. (1997). Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511-520.
25. Kenny, B., Devinney, R., Stein, M., Reinscheid, D.J., Frey, E.A., and Finlay, B.B. (1999). Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511-520.
26. Klinghoffer, R.A., Mueting-Nelsen, P.F., Faerman, A., Shani, M., and Soriano, P. (2001). The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol. Cell 7, 343-354.
27. Knutton, S., Shaw, R., McNeish, A.S., Philips, A., Price, E., and Watson, P. (1989). Diagnosis of enteropathogenic Escherichia coli. Lancet 2, 218.
28. Koleske, A.J., Gifford, A.M., Scott, M.L., Nee, M., Bronson, R.T., Miczek, K.A., and Baltimore, D. (1998). Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259-1272.
29. Kraker, A.J., Hartl, B.C., Amar, A.M., Barvian, M.R., Showalter, H.D., and Moore, C.W. (2000). Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. Biochem. Pharmacol. 60, 885-898.
30. Laneuville, P. (1995). Abl tyrosine protein kinase. Semin. Immunol. 7, 255-266.
31. Lanier, L.M., and Gertler, F.B. (2000). From Abl to actin: Abl tyrosine kinase and associated proteins in growth cone morility. Curr. Opin. Neurobiol. 10, 80-87.
32. Li, S., Yamauchi, A., Marchal, C.C., Molitoris, J.K., Quilliam, L.A., and Dinauer, M.C. (2002). Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions. J. Immunol. 169, 5043-5051.
33. Liu, Y., Bishop, A., Witucki, L., Kraybill, B., Shimizu, E., Tsien, J., Ubersax, J., Blethrow, J., Morgan, D.O., and Shokat, K.M. (1999). Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol. 6, 671-678.
34. Lommel, S., Benesch, S., Rottner, K., Franz, T., Wehland, J., and Kuhn, R. (2001). Actin pedestal formation by enteropathogenic Escherichia coli and intracellular motility of Shigella flexneri are abolished in N-WASP-defective cells. EMBO Rep. 2, 850-857.
35. Mead, P.S., Slutsker, L., Dietz, V., McCaig, L.F., Bresee, J.S., Shapiro, C., Griffin, P.M., and Tauxe, R.V. (1999). Food-related illness and death in the United States. Emerg. Infect. Dis. 5, 607-625.
36. Nagar, B., Bornmann, W.G., Pellicena, P., Schindler, T., Veach, D.R., Miller, W.T., Clarkson, B., and Kuriyan, J. (2002). Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. 62, 4236-4243.
37. Pendergast, A.M. (2002). The Abl family kinases: mechanisms of regulation and signaling. Adv. Cancer Res. 85, 51-100.
38. Plattner, R., Kadlec, L., DeMali, K.A., Kazlauskas, A., and Pendergast, A.M. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13, 2400-2411.
39. Pluk, H., Dorey, K., and Superti-Furga, G. (2002). Autoinhibition of c-Abl. Cell. 108, 247-259.
40. Raitano, A.B., Whang, Y.E., and Sawyers, C.L. (1997). Signal transduction by wild-type and leukemogenic Abl proteins. Biochim. Biophys. Acta 1333, F201-F216.
41. Ren, R., Ye, Z.S., and Baltimore, D. (1994). Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8, 783-795.
42. Riley, L.W., et al. (1983). Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308, 681-685.
43. Robinson, D.R., Wu, Y.M., and Lin, S.F. (2000). The protein tyrosine kinase family of the human genome. Oncogene 19, 5548-5557.
44. Rohatgi, R., Ma, L., Miki, H., Lopez, M., Kirchhausen, T., Takenawa, T., and Kirschner, M.W. (1999). The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97, 221-231.
45. Rosenshine, I., Donnenberg, M.S., Kaper, J.B., and Finlay, B.B. (1992). Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO J. 11, 3551-3560.
46. Rosenshine, I., and Finlay, B.B. (1993). Enteropathogenic Escherichia coli Epec activates protein tyrosine kinase Tpk in infected epithelial cells characterization of the major Tpk substrate. Abstr. Gen. Meet. Am. Soc. Microbiol. 93, 73.
47. Rosenshine, I., Ruschkowski, S., Stein, M., Reinscheid, D.J., Mills, S.D., and Finlay, B.B. (1996). A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates actin pseudopod formation. EMBO J. 15, 2613-2624.
48. Schindler, T., Bornmann, W., Pellicena, P., Miller, W.T., Clarkson, B., and Kuriyan, J. (2000). Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289, 1938-1942.
49. Schwartzberg, P.L., Stall, A.M., Hardin, J.D., Bowdish, K.S., Humaran, T., Boast, S., Harbison, M.L., Robertson, E.J., and Goff, S.P. (1991). Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165-1175.
50. Sinclair, J.F., and O'Brien, A.D. (2002). Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O 157, H7. J. Biol. Chem. 277, 2876-2885.
51. Smith, J.M., Katz, S., and Mayer, B.J. (1999). Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the SrSrc homology 2/SrSrc homology 3 adaptor Nck. J. Biol. Chem. 274, 27956-27962.
52. Smith, J.M., and Mayer, B.J. (2002). Abl: mechanisms of regulation and activation. Front. Biosci. 7, d31-d42.
53. Stein, P.L., Vogel, H., and Soriano, P. (1994). Combined deficiencies of SrSrc, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8, 1999-2007.
54. Swedlow, J.R., Sedat, J.W., and Agard, D.A. (1997). Deconvolution in optical microscopy. In: Deconvolution of Images and Spectra, ed. P.A. Jansson, San Diego: Academic Press, 284-307.
55. Tanaka, M., Gupta, R., and Mayer, B.J. (1995). Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell Biol. 15, 6829-6837.
56. Tatton, L., Morley, G.M., Chopra, R., and Khwaja, A. (2003). The SrSrc-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem. 278, 4847-4853.
57. Ting, A.Y., Kain, K.H., Klemke, R.L., and Tsien, R.Y. (2001). Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc. Natl. Acad. Sci. USA 98, 15003-15008.
58. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
59. Wang, J.Y. (1988). Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids. Oncogene Res. 3, 293-298.
60. Wisniewski, D., et al. (2002). Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer Res. 62, 4244-4255.
61. Woodring, P.J., Hunter, T., and Wang, J.Y. (2001). Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J. Biol. Chem. 276, 27104-27110.
62. Woodring, P.J., Litwack, E.D., O'Leary, D.D., Lucero, G.R., Wang, J.Y., and Hunter, T. (2002). Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J. Cell Biol. 156, 879-892.